PT2912465T - Metilglioxal como marcador para o cancro - Google Patents

Metilglioxal como marcador para o cancro

Info

Publication number
PT2912465T
PT2912465T PT137830733T PT13783073T PT2912465T PT 2912465 T PT2912465 T PT 2912465T PT 137830733 T PT137830733 T PT 137830733T PT 13783073 T PT13783073 T PT 13783073T PT 2912465 T PT2912465 T PT 2912465T
Authority
PT
Portugal
Prior art keywords
methylglioxal
marker
cancer
Prior art date
Application number
PT137830733T
Other languages
English (en)
Portuguese (pt)
Inventor
Belpomme Dominique
Irigaray Philippe
Original Assignee
Association Pour La Rech Therapeutique Anti Cancereuse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association Pour La Rech Therapeutique Anti Cancereuse filed Critical Association Pour La Rech Therapeutique Anti Cancereuse
Publication of PT2912465T publication Critical patent/PT2912465T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PT137830733T 2012-10-25 2013-10-25 Metilglioxal como marcador para o cancro PT2912465T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/071163 WO2014063743A1 (en) 2012-10-25 2012-10-25 Methylglyoxal as a marker of cancer

Publications (1)

Publication Number Publication Date
PT2912465T true PT2912465T (pt) 2018-01-25

Family

ID=47074733

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137830733T PT2912465T (pt) 2012-10-25 2013-10-25 Metilglioxal como marcador para o cancro

Country Status (11)

Country Link
US (1) US20150301056A1 (https=)
JP (1) JP6543193B2 (https=)
CN (1) CN104854458B (https=)
CA (1) CA2889110A1 (https=)
DK (1) DK2912465T3 (https=)
ES (1) ES2656896T3 (https=)
MA (1) MA38042B2 (https=)
PT (1) PT2912465T (https=)
RU (1) RU2666255C2 (https=)
TN (1) TN2015000161A1 (https=)
WO (2) WO2014063743A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106769349B (zh) * 2017-01-06 2020-01-21 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN108426996B (zh) * 2017-02-15 2020-09-15 江苏美正生物科技有限公司 一种3-甲基喹噁啉-2-羧酸残留的快速检测试剂盒及其制备方法和应用
GB2566681B (en) * 2017-09-14 2021-07-28 Ip2Ipo Innovations Ltd Biomarker
CN108061802A (zh) * 2017-12-08 2018-05-22 武汉科技大学 一种通过血液检测评定乳腺癌的方法
SG11202104101TA (en) * 2018-11-28 2021-05-28 Nat Univ Singapore Method of detecting cancer and/or tuberculosis
CN110604823B (zh) * 2019-10-21 2020-10-20 兰州大学 一种快速筛选抗糖化和/或抗衰老物质的方法
CN113376199A (zh) * 2021-05-12 2021-09-10 兰立生物科技(苏州)有限公司 一种用于癌症检测的生化分析检测系统
CN114496306B (zh) * 2022-01-28 2022-12-20 北京大学口腔医学院 基于机器学习的预后生存阶段预测方法和系统
US20220206017A1 (en) * 2022-03-18 2022-06-30 Joel Steven Goldberg Aerobic glycolysis and hypermetabolic states

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007073005A1 (ja) * 2005-12-22 2009-06-04 学校法人慶應義塾 メチル基転移反応調節物質
US8026049B2 (en) * 2007-03-23 2011-09-27 Wisconsin Alumni Research Foundation Noninvasive measurement and identification of biomarkers in disease state
JP4836926B2 (ja) * 2007-11-12 2011-12-14 株式会社日本トリム 糖分解代謝物の測定方法
JP5787339B2 (ja) * 2009-12-28 2015-09-30 学校法人福岡大学 糖尿病前症の検査方法
KR20140024860A (ko) * 2011-02-24 2014-03-03 버밀리언, 인코포레이티드 난소암에 대한 바이오마커 패널,진단 방법 및 시험 키트

Also Published As

Publication number Publication date
CN104854458B (zh) 2018-02-09
CA2889110A1 (en) 2014-05-01
JP6543193B2 (ja) 2019-07-10
RU2666255C2 (ru) 2018-09-06
MA38042A3 (fr) 2018-03-30
CN104854458A (zh) 2015-08-19
RU2015119512A (ru) 2016-12-20
US20150301056A1 (en) 2015-10-22
MA38042B2 (fr) 2019-11-29
JP2016500821A (ja) 2016-01-14
DK2912465T3 (en) 2018-01-15
ES2656896T3 (es) 2018-02-28
MA38042A2 (fr) 2017-02-28
WO2014063743A1 (en) 2014-05-01
TN2015000161A1 (en) 2016-10-03
WO2014064283A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
BR112015013444A2 (pt) métodos para caracterizar um câncer
IL237791A0 (en) Method of treating cancer
EP2829421A4 (en) TIRE
EP2912485A4 (en) POSITIONING
EP2818334A4 (en) TIRE
EP2821251A4 (en) TIRES
EP2878300A4 (en) PLASTER
EP2823973A4 (en) TIRE
EP2865468A4 (en) Cutting tool
PT2912465T (pt) Metilglioxal como marcador para o cancro
HUE045314T2 (hu) Kombinációs terápia rák kezelésére
EP2853416A4 (en) TIRE
EP2927024A4 (en) TIRE
EP2821248A4 (en) TIRES
EP2810793A4 (en) TIRE
EP2821249A4 (en) TIRES
HUE043162T2 (hu) Eljárás rák detektálására
EP2859892C0 (en) PAVEMENT
EP2821250A4 (en) TIRES
EP2911563A4 (en) DONOR
EP2905148A4 (en) TIRE
EP2868494A4 (en) TIRE
EP2821252A4 (en) TIRES
DK2708607T3 (da) Genetiske markører for Myb28
EP2826578A4 (en) Cutting tool